The following statement is copied from a publicly traded company's annual report: (MILLIONS) Net income before allocation to noncontrolling interests Foreign currency translation adjustments, net Year Ended December 31, 2018 2019 2017 $ 16,302 $ 11,188 $ 21,355 $ 654 $ (799) $ 1.116 Reclassification adjustments (288) (22) 162 366 (821) 1,278 Unrealized holding gains/(losses) on derivative financial instruments, net 476 220 (10) Reclassification adjustments for (gains)/losses included in net income (664) 27 (520) (188) 247 (530) Unrealized holding gains/(losses) on available-for-sale securities, net (1) (185) 818 Reclassification adjustments for (gains)/losses included in net income Reclassification adjustments for unrealized gains included in Retained eamings 39 124 (244) (462) 38 (522) 574 Benefit plans: actuarial losses, net (826) (649) (212) Reclassification adjustments related to amortization 241 242 588 Reclassification adjustments related to settlements, net 274 142 117 Other 22 112 (145) (289) (153) 348 Benefit plans: prior service costs and other, net Reclassification adjustments related to amortization of prior service costs and other, net Reclassification adjustments related to curtailments of prior service costs and other net Other Other comprehensive income/(loss), before tax Tax provision/(benefit) on other comprehensive income/(loss) Other comprehensive income/(loss) before allocation to noncontrolling interests Comprehensive income before allocation to noncontrolling interests Less: Comprehensive income attributable to noncontrolling interests Comprehensive income attributable to Pfizer Inc. What is this statement? $ 15,926 $ 9.214 $ 23,085 18 16 62 $ 15.908 5 9.196 $ 23,023 (7) (9) (2) (181) (181) (184) (2) (19) (18) 1 2 (189) (207) (203) (262) (1.457) 1,468 115 518 (262) $ (376) $ (1.975) $ 1,730 Statement cash flows O Statement of financial position Statement of income O Statement of comprehensive income